Abstract
Intravenous inoculation of a group A hemolytic streptococcus caused lethal infections in all of eight untreated monkeys. Intramuscular injections of clindamycin-2-phosphate in a daily dose of 25 mg/kg given in equal morning and afternoon doses for 10 days resulted in survival of all of eight monkeys. Similar results were observed with the same dose schedule of clindamycin hydrochloride given intragastrically; no fatalities occurred among eight monkeys. In monkeys receiving erythromycin stearate intragastrically or methicillin intramuscularly, three of eight and four of eight monkeys, respectively, died. Duration of both illness and positive blood cultures was greater in the erythromycin- and methicillin-treated survivors than in the clindamycin-treated monkeys. The differences in results between clindamycin and erythromycin could not be correlated with serum antibacterial activity levels, which were similar, or with minimal inhibitory concentrations, which were 0.02 μg/ml with both antibiotics. With methicillin, however, the minimal inhibitory concentration was 0.16 μg/ml and serum antibacterial activity varied from titers of less than 1:2 to 1:8. As in previous studies of staphylococcal infections in monkeys with the same antibiotics, in vitro susceptibility data and serum antibacterial activity did not completely correlate with in vivo results.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carlisle H. N., Saslaw S. Therapy of staphylococcal infections in monkeys. VI. Comparison of clindamycin, erythromycin, and methicillin. Appl Microbiol. 1971 Mar;21(3):440–446. doi: 10.1128/am.21.3.440-446.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perkins R. L., Carlisle H. N., Saslaw S. Cephalexin: in vitro bacterial susceptibility, absorption in volunteers, and antibacterial activity of sera and urine. Am J Med Sci. 1968 Aug;256(2):122–129. [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Comparison of cephalexin, penicillin V, and ampicillin in streptococcal infections in monkeys. Appl Microbiol. 1970 Jun;19(6):943–949. doi: 10.1128/am.19.6.943-949.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Comparison of cephalothin, cephaloridine, cephalexin and cephaloglycin in streptococcal infections in monkeys. Am J Med Sci. 1969 Jun;257(6):395–407. doi: 10.1097/00000441-196906000-00006. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N., Marietti M. Therapy of staphylococcal infections in monkeys. IV. Further comparison of triacetyloleandomycin and erythromycins. Appl Microbiol. 1969 Dec;18(6):1077–1083. doi: 10.1128/am.18.6.1077-1083.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N., Sparks J. Studies on therapy of staphylococcal infections in monkeys. V. Comparison of cephalexin, oxacillin, cloxacillin, dicloxacillin and nafcillin. Am J Med Sci. 1970 Feb;259(2):143–152. doi: 10.1097/00000441-197002000-00008. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Studies of therapy of staphylococcal infections in monkeys. II. Comparison of cloxacillin, dicloxacillin, and leucomycin. Proc Soc Exp Biol Med. 1968 Jun;128(2):358–363. doi: 10.3181/00379727-128-33014. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Studies on therapy of staphylococcal infections in monkeys. 3. Comparison of cephalothin, cephaloridine and cephalexin. Am J Med Sci. 1968 Sep;256(3):136–149. doi: 10.1097/00000441-196809000-00002. [DOI] [PubMed] [Google Scholar]
- Saslaw S., Carlisle H. N. Studies on therapy of staphylococcal infections in monkeys. I. Comparison of cloxacillin, triacetyloleandomycin and erythromycin. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1168–1173. doi: 10.3181/00379727-125-32304. [DOI] [PubMed] [Google Scholar]